Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer

Molecular Therapy Oncolytics

Volumn 3, Issue , 2016, Pages 16018-

  Jiao, Demin ^a   Wang, Jian ^a   Lu, Wei ^a   Tang, Xiali ^a   Chen, Jun ^a   Mou, Hao ^a   Chen, Qing Yong ^a  

^a The 117th Hospital of Chinese PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD34 ANTIGEN; CURCUMIN; MAMMALIAN TARGET OF RAPAMYCIN; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BALB/C NUDE MOUSE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LUNG CANCER; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84992478160     PISSN: None     EISSN: 23727705     Source Type: Journal    
DOI: 10.1038/mto.2016.18     Document Type: Article

References (51)

1. Iwatsuki, M, Mimori, K, Yokobori, T, Ishi, H, Beppu, T, Nakamori, S et al. (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-299.
2. Meng, F and Wu, G (2012). The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis. Cancer Metastasis Rev 31: 455-467.
3. Gao, D, Vahdat, LT, Wong, S, Chang, JC and Mittal, V (2012). Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res 72: 4883-4889.
4. Gentile, A, Trusolino, L and Comoglio, PM (2008). The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 27: 85-94.
5. Feng, Y, Minca, EC, Lanigan, C, Liu, A, Zhang, W, Yin, L et al. (2014). High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer. J Thorac Oncol 9: 646-653.
6. Umeguchi, H, Sueoka-Aragane, N, Kobayashi, N, Nakamura, T, Sato, A, Takeda, Y et al. (2015). Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Oncol Rep 33: 391-396.
7. Keedy, VL and Sandler, AB (2007). Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Cancer Sci 98: 1825-1830.
8. Bohonowych, JE, Gopal, U and Isaacs, JS (2010). Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls. J Oncol 2010: 412985.
9. Trusolino, L and Comoglio, PM (2002). Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2: 289-300.
10. Graupera, M and Potente, M (2013). Regulation of angiogenesis by PI3K signaling networks. Exp Cell Res 319: 1348-1355.
11. Eder, J P, Vande Woude, GF, Boerner, SA and LoRusso, PM (2009). Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15: 2207-2214.
12. Chen, Q, Wang, Y, Xu, K, Lu, G, Ying, Z, Wu, L et al. (2010). Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol Rep 23: 397-403.
13. Li, L, Braiteh, FS and Kurzrock, R (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331.
14. Kim, SY, Jung, SH and Kim, HS (2005). Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337: 510-516.
15. Singh, M and Singh, N (2011). Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol Cell Biochem 347: 1-11.
16. Yu, T, Li, J, Qiu, Y and Sun, H (2012). 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation. Mol Cell Biochem 361: 47-54.
17. Chen, QY, Shi, JG, Yao, QH, Jiao, DM, Wang, YY, Hu, HZ et al. (2012). Lysosomal membrane permeabilization is involved in curcumin-induced apoptosis of A549 lung carcinoma cells. Mol Cell Biochem 359: 389-398.
18. Ji, C, Cao, C, Lu, S, Kivlin, R, Amaral, A, Kouttab, N et al. (2008). Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 62: 857-865.
19. Lin, SS, Lai, KC, Hsu, SC, Yang, JS, Kuo, CL, Lin, JP et al. (2009). Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett 285: 127-133.
20. Chen, QY, Zheng, Y, Jiao, DM, Chen, FY, Hu, HZ, Wu, YQ et al. (2014). Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem 25: 177-185.
21. Chen, QY, Jiao, DM, Wang, LF, Wang, L, Hu, HZ, Song, J et al. (2015). Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1. Mol Biosyst 11: 859-868.
22. Chen, HW, Lee, JY, Huang, JY, Wang, CC, Chen, WJ, Su, SF et al. (2008). Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68: 7428-7438.
23. Huang, T, Chen, Z and Fang, L (2013). Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells. Oncol Rep 29: 117-124.
24. Chen, WC, Lai, YA, Lin, YC, Ma, JW, Huang, LF, Yang, NS et al. (2013). Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells. J Agric Food Chem 61: 11817-11824.
25. Gururaj, AE, Belakavadi, M, Venkatesh, DA, Marmé, D and Salimath, BP (2002). Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297: 934-942.
26. Perry, MC, Demeule, M, Régina, A, Moumdjian, R and Béliveau, R (2010). Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res 54: 1192-1201.
27. Nagai, T, Arao, T, Furuta, K, Sakai, K, Kudo, K, Kaneda, H et al. (2011). Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther 10: 169-177.
28. Matsumoto, K and Nakamura, T (2006). Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119: 477-483.
29. Chang, L, Graham, PH, Hao, J, Ni, J, Bucci, J, Cozzi, PJ et al. (2013). Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4: e875.
30. Zhang, YW, Su, Y, Volpert, OV and Vande Woude, GF (2003). Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 100: 12718-12723.
31. Usatyuk, PV, Fu, P, Mohan, V, Epshtein, Y, Jacobson, JR, Gomez-Cambronero, J et al. (2014). Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells. J Biol Chem 289: 13476-13491.
32. Masago, K, Togashi, Y, Fujita, S, Sakamori, Y, Okuda, C, Kim, YH et al. (2012). Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib. Med Oncol 29: 1614-1621.
33. Bharti, A, Ma, PC, Maulik, G, Singh, R, Khan, E, Skarin, AT et al. (2004). Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 24(2C): 1031-1038.
34. Thiery, JP and Sleeman, JP (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
35. Elliott, BE, Hung, WL, Boag, AH and Tuck, AB (2002). The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can J Physiol Pharmacol 80: 91-102.
36. Whittaker, S, Marais, R and Zhu, AX (2010). The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29: 4989-5005.
37. Sun, LN, Chen, ZX, Liu, XC, Liu, HY, Guan, GJ and Liu, G (2014). Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1. Biomed Pharmacother 68: 1079-1088.
38. Peruzzi, B and Bottaro, DP (2006). Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12: 3657-3660.
39. Sun, XD, Liu, XE and Huang, DS (2013). Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep 29: 2401-2407.
40. Ponzo, MG, Lesurf, R, Petkiewicz, S, O'Malley, FP, Pinnaduwage, D, Andrulis, IL et al. (2009). Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA 106: 12903-12908.
41. Zou, HY, Li, Q, Lee, JH, Arango, ME, McDonnell, SR, Yamazaki, S et al. (2007). An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res 67: 4408-4417.
42. Heideman, DA, van Beusechem, VW, Bloemena, E, Snijders, PJ, Craanen, ME, Offerhaus, GJ et al. (2004). Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. J Gene Med 6: 317-327.
43. Ichimura, E, Maeshima, A, Nakajima, T and Nakamura, T (1996). Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn J Cancer Res 87: 1063-1069.
44. Gumustekin, M, Kargi, A, Bulut, G, Gozukizil, A, Ulukus, C, Oztop, I et al. (2012). HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer. Pathol Oncol Res 18: 209-218.
45. Birchmeier, C, Birchmeier, W, Gherardi, E and Vande Woude, GF (2003). Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
46. Hong, SW, Jung, KH, Lee, HS, Son, MK, Yan, HH, Kang, NS et al. (2013). SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis 34: 2156-2169.
47. Xin, X, Yang, S, Ingle, G, Zlot, C, Rangell, L, Kowalski, J et al. (2001). Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158: 1111-1120.
48. Rainey, N, Motte, L, Aggarwal, BB and Petit, PX (2015). Curcumin hormesis mediates a cross-talk between autophagy and cell death. Cell Death Dis 6: e2003.
49. Moustapha, A, Pérétout, PA, Rainey, NE, Sureau, F, Geze, M, Petit, JM, et al. (2015). Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events. Cell Death Discovery 1: 15017.
50. Subramani, R, Gonzalez, E, Arumugam, A, Nandy, S, Gonzalez, V, Medel, J et al. (2016). Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition. Sci Rep 6: 19819.
51. Kunwar, A, Barik, A, Pandey, R and Priyadarsini, KI (2006). Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta 1760: 1513-1520.